Tang Capital Management LLC Tcr2 Therapeutics Inc. Transaction History

Tang Capital Management LLC

  • $819 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.0 - $1.62 $660,798 - $1.07 Million
660,798 Added 24.13%
3,399,745 $5.1 Million
Q4 2022

Feb 14, 2023
SELL
$0.83 - $1.44 $749,206 - $1.3 Million
-902,659 Reduced 24.79%
2,738,947 $2.74 Million
Q2 2022

Aug 15, 2022
BUY
$2.11 - $2.94 $1.35 Million - $1.89 Million
641,606 Added 21.39%
3,641,606 $10.6 Million
Q1 2022

May 16, 2022
BUY
$2.4 - $4.71 $7.2 Million - $14.1 Million
3,000,000 New
3,000,000 $8.28 Million

About TCR2 THERAPEUTICS INC.

TCRR Quotes by TradingView
  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email